<DOC>
	<DOCNO>NCT02851446</DOCNO>
	<brief_summary>Non-invasive nocturnal ventilation effective treatment chronic respiratory failure , whether due obstructive ( COPD ) , restrictive neuromuscular cause , notably patient last two category significantly prolongs life expectancy . Overall , treatment well tolerate , principal adverse effect discomfort relate mask . In certain patient , morning dyspnoea mask remove describe . This disable limit everyday activity least 30 minute , defines deventilation syndrome . The pathophysiology syndrome uncertain , notably roles hyperinflation , patient/ventilator asynchrony , sudden increase diaphragmatic work night rest . The aim study investigate prevalence factor associate reventilation syndrome ( DS ) population patient ventilation whatever reason , stable state , follow medical device department Dijon CHU , good understand mechanism . Patients DS subsequently invite participate therapeutic trial .</brief_summary>
	<brief_title>Prevalence Risk Factors Reventilation Syndrome Population Patients Under Ventilation Whatever Reason</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<criteria>patient 18 year old ventilation whatever reason ST mode life support 1 month last episode respiratory decompensation guardianship inability understand instruction provide consent uncontrolled psychiatric disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>